Director Gaurav Aggarwal resigns from Unicycive board effective April 6

Unicycive Therapeutics, Inc.

Gaurav Aggarwal resigned from the Board of Directors on April 6, 2026.
Resignation was not due to any disagreement with the Company or management.
Company expressed gratitude for Dr. Aggarwal's service on the Board.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gaurav Aggarwal

Director

UNCY · Unicycive Therapeutics, Inc.

Effective: 2026-04-06
Filed: Apr 06, 2026 23:59 UTC

On April 6, 2026, Gaurav Aggarwal, a director of Unicycive Therapeutics, Inc. (the “Company”), resigned from the Board of Directors of the Company.

Source: SEC EDGAR

accession 0001213900-26-040179

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.